These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20656791)

  • 21. SKI knockdown inhibits human melanoma tumor growth in vivo.
    Chen D; Lin Q; Box N; Roop D; Ishii S; Matsuzaki K; Fan T; Hornyak TJ; Reed JA; Stavnezer E; Timchenko NA; Medrano EE
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):761-72. PubMed ID: 19845874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant TGFβ Signaling Contributes to Altered Trophoblast Differentiation in Preeclampsia.
    Xu J; Sivasubramaniyam T; Yinon Y; Tagliaferro A; Ray J; Nevo O; Post M; Caniggia I
    Endocrinology; 2016 Feb; 157(2):883-99. PubMed ID: 26653761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
    J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells.
    Dooley S; Delvoux B; Streckert M; Bonzel L; Stopa M; ten Dijke P; Gressner AM
    FEBS Lett; 2001 Jul; 502(1-2):4-10. PubMed ID: 11478938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
    van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
    Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SKI promotes Smad3 linker phosphorylations associated with the tumor-promoting trait of TGFbeta.
    Lin Q; Chen D; Timchenko NA; Medrano EE
    Cell Cycle; 2010 May; 9(9):1684-9. PubMed ID: 20404506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells.
    Ammanamanchi S; Tillekeratne MP; Ko TC; Brattain MG
    Cancer Res; 2004 Apr; 64(7):2509-15. PubMed ID: 15059906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
    Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
    Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling.
    Petrocca F; Vecchione A; Croce CM
    Cancer Res; 2008 Oct; 68(20):8191-4. PubMed ID: 18922889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repression of Smad3 by Stat3 and c-Ski/SnoN induces gefitinib resistance in lung adenocarcinoma.
    Makino Y; Yoon JH; Bae E; Kato M; Miyazawa K; Ohira T; Ikeda N; Kuroda M; Mamura M
    Biochem Biophys Res Commun; 2017 Mar; 484(2):269-277. PubMed ID: 28115165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
    Tsang KJ; Tsang D; Brown TN; Crowe DL
    Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Filamin associates with Smads and regulates transforming growth factor-beta signaling.
    Sasaki A; Masuda Y; Ohta Y; Ikeda K; Watanabe K
    J Biol Chem; 2001 May; 276(21):17871-7. PubMed ID: 11278410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells.
    Yang J; Wahdan-Alaswad R; Danielpour D
    Cancer Res; 2009 Mar; 69(6):2185-90. PubMed ID: 19276350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
    Ferrand N; Atfi A; Prunier C
    Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
    Dunfield LD; Nachtigal MW
    Oncogene; 2003 Jul; 22(30):4745-51. PubMed ID: 12879019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
    Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3.
    Kim SG; Kim HA; Jong HS; Park JH; Kim NK; Hong SH; Kim TY; Bang YJ
    Mol Biol Cell; 2005 Oct; 16(10):4672-83. PubMed ID: 16093355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.